경카테터 승모판 치환술(TMVR) : 세계 시장 점유율과 순위, 총판매량 및 수요 예측(2025-2031년)
Transcatheter Mitral Valve Replacement (TMVR) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
상품코드:1867528
리서치사:QYResearch
발행일:2025년 10월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 경카테터 승모판 치환술(TMVR) 시장 규모는 2024년에 10억 8,100만 달러로 추정되며, 2025-2031년의 예측 기간에 CAGR 15.7%로 확대하며, 2031년까지 28억 8,800만 달러에 달할 것으로 예측되고 있습니다.
이 보고서는 경피적 카테터 승모판막 치환술(TMVR)에 대한 최근 관세 조정과 국제적인 전략적 대응 조치에 대해 국경 간 산업적 발자취, 자본 배분 패턴, 지역 경제의 상호의존성, 공급망 재구축을 종합적으로 평가합니다.
TMVR(경카테터 승모판막 치환술)은 기존의 개흉수술 없이 심장 승모판막을 교체하는 방법입니다. TMVR은 승모판막 협착증(판막이 좁아진 상태)이나 승모판막 역류증(판막이 새는 상태) 또는 두 가지 모두에 대한 치료법으로 사용됩니다. TMVR은 초기에는 수술 위험이 너무 높다고 판단되는 환자의 승모판막 치환술로 개발되었으나, 기술의 발전과 치료성적의 확립으로 향후 수술적 승모판막 치환술을 대체할 수 있는 가능성이 있습니다. 2024년 세계 TMVR 생산량은 약 3만 6,000대, 평균 시장 가격은 대당 약 3만 달러에 달했습니다.
고령화 사회가 가속화됨에 따라 특히 북미, 유럽, 아시아태평양 일부 등 선진국에서 심부전 및 심장판막증 발생률이 지속적으로 증가하고 있습니다. TMVR은 복잡한 해부학적 구조에 대한 적응성, 수술 후 위험 감소, 기존 수술에 비해 빠른 회복 속도로 주목받고 있습니다. 주요 의료기기 제조업체들은 연례 보고서에서 구조적 심장질환 분야의 전략적 중요성을 강조하고 있으며, 여러 개발 파이프라인이 TMVR 기술에 초점을 맞추었습니다. 또한 지원적인 상환제도 개혁과 근거중심의 의료정책도 TMVR 솔루션 시장 수용성 확대에 기여하고 있습니다.
지속적인 기술 혁신에도 불구하고 TMVR은 여전히 안전한 배송, 장기 내구성, 정밀한 배포와 같은 기술적 과제에 직면해 있습니다. 연구개발의 높은 진입장벽과 승인 절차의 장기화를 반영하듯, 후기 임상시험 단계 또는 상업화 단계에 진입한 세계 기업은 극히 일부에 불과합니다. 많은 국가에서 규제 프레임워크가 정비되고 있으며, 임상팀은 첨단 다직종 협업 기술을 필요로 합니다. 이러한 장벽은 특히 의료시스템이 미성숙한 지역에서는 단기적으로 시장 확대가 둔화될 수 있습니다.
TMVR의 주요 환자층은 기존 수술이 적응증이 없거나 고위험군으로 분류되는 환자들입니다. 북미와 유럽에서는 이 계층에서 강력한 교체 수요가 있습니다. 영상 진단 기술과 카테터 전달 시스템의 발전으로 이 시술은 보다 광범위한 적응증에 접근이 용이하고 적용 범위가 넓어지고 있습니다. 신흥 아시아태평양 시장에서는 국제 공동 임상 및 조기 임상 도입으로 현지 시장의 수용 태세가 가속화되고 있으며, 중기적 성장 가능성이 기대됩니다.
이 보고서는 경피적 카테터 승모판막 치환술(TMVR) 세계 시장에 대해 총판매량, 매출, 가격, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고 지역별, 국가별, 유형별, 용도별 분석을 종합적으로 제시하는 것을 목적으로 합니다.
경카테터 승모판막 치환술(TMVR) 시장 규모 추정 및 예측은 판매량(천 단위) 및 매출액(백만 달러)으로 제시되며, 2024년을 기준 연도, 2020-2031년의 과거 데이터와 예측 데이터를 포함하는 2024-2031년 예측됩니다. 정량적, 정성적 분석을 통해 경피적 승모판막 치환술(TMVR) 관련 비즈니스/성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 포지셔닝 분석, 정보에 입각한 비즈니스 의사결정을 내릴 수 있도록 도와드립니다.
시장 세분화
기업별
Abbott
Edwards Lifesciences
Medtronic
Boston Scientific
Micro Interventional Devices
Neovasc
Zhenyi Medical
Highlife Medical
유형별 부문
MitraClip
Edwards PASCAL
Edwards SAPIEN 3
용도별 부문
기능성 승모판 폐쇄 부전증(FMR)
변성성 승모판 폐쇄 부전증(DMR)
지역별
북미
미국
캐나다
아시아태평양
중국
일본
한국
동남아시아
인도
호주
기타 아시아태평양
유럽
독일
프랑스
영국
이탈리아
네덜란드
북유럽 국가
기타 유럽
라틴아메리카
멕시코
브라질
기타 라틴아메리카
중동 및 아프리카
튀르키예
사우디아라비아
아랍에미리트
기타 중동 및 아프리카
KSA
영문 목차
영문목차
The global market for Transcatheter Mitral Valve Replacement (TMVR) was estimated to be worth US$ 1081 million in 2024 and is forecast to a readjusted size of US$ 2888 million by 2031 with a CAGR of 15.7% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Transcatheter Mitral Valve Replacement (TMVR) cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
TMVR, also known as transcatheter mitral valve replacement is a way of replacing the mitral valve in the heart without the need for conventional open-heart surgery. TMVR transcatheter mitral valve replacement is a treatment for mitral valve stenosis (tight mitral valve) or mitral valve regurgitation (leaky mitral valve) or a mix of the two. TMVR transcatheter mitral valve replacement was developed initially as a method of replacing the mitral valve in patients considered too high risk for surgery but will likely replace mitral valve replacement surgery in the future as the technology improves and the outcomes are proved.In 2024, globalTMVR production reached approximately 36 k units , with an average global market price of around 30 k USD/Unit.
With the accelerating aging population, the incidence of heart failure and valvular heart diseases continues to rise, especially in developed regions like North America, Europe, and parts of Asia-Pacific. TMVR is gaining traction due to its adaptability to complex anatomies, reduced post-operative risks, and faster recovery compared to traditional surgery. Leading medtech companies have emphasized the strategic importance of structural heart disease segments in their annual reports, with several pipeline programs focused on TMVR technologies. Supportive reimbursement reforms and evidence-based health policies are also contributing to the growing market acceptance of TMVR solutions.
Despite continuous innovation, TMVR still faces technical challenges in safe delivery, long-term durability, and precise deployment. Only a few global players have advanced to late-stage clinical or commercial phases, reflecting high R&D thresholds and extended approval timelines. Regulatory frameworks remain in development in many countries, and clinical teams must be highly skilled in multidisciplinary collaboration. These barriers may slow near-term market expansion, particularly in less mature healthcare systems.
The main patient base for TMVR consists of those ineligible for traditional surgery or classified as high risk. In North America and Europe, this segment shows strong replacement demand. With advancements in imaging and catheter delivery systems, the procedure is becoming more accessible and applicable to broader indications. In emerging Asia-Pacific markets, international collaborative trials and early clinical adoption are accelerating local market readiness, indicating promising mid-term growth potential.
This report aims to provide a comprehensive presentation of the global market for Transcatheter Mitral Valve Replacement (TMVR), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Transcatheter Mitral Valve Replacement (TMVR) by region & country, by Type, and by Application.
The Transcatheter Mitral Valve Replacement (TMVR) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcatheter Mitral Valve Replacement (TMVR).
Market Segmentation
By Company
Abbott
Edwards Lifesciences
Medtronic
Boston Scientific
Micro Interventional Devices
Neovasc
Zhenyi Medical
Highlife Medical
Segment by Type
MitraClip
Edwards PASCAL
Edwards SAPIEN 3
Segment by Application
Functional Mitral Regurgitation (FMR)
Degenerative Mitral Regurgitation (DMR)
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Transcatheter Mitral Valve Replacement (TMVR) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Transcatheter Mitral Valve Replacement (TMVR) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Transcatheter Mitral Valve Replacement (TMVR) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
2.9.2 Global 5 and 10 Largest Manufacturers by Transcatheter Mitral Valve Replacement (TMVR) Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcatheter Mitral Valve Replacement (TMVR) as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 MitraClip
3.1.2 Edwards PASCAL
3.1.3 Edwards SAPIEN 3
3.2 Global Transcatheter Mitral Valve Replacement (TMVR) Sales Value by Type
3.2.1 Global Transcatheter Mitral Valve Replacement (TMVR) Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Transcatheter Mitral Valve Replacement (TMVR) Sales Value, by Type (2020-2031)
3.2.3 Global Transcatheter Mitral Valve Replacement (TMVR) Sales Value, by Type (%) (2020-2031)
3.3 Global Transcatheter Mitral Valve Replacement (TMVR) Sales Volume by Type
3.3.1 Global Transcatheter Mitral Valve Replacement (TMVR) Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Transcatheter Mitral Valve Replacement (TMVR) Sales Volume, by Type (2020-2031)
3.3.3 Global Transcatheter Mitral Valve Replacement (TMVR) Sales Volume, by Type (%) (2020-2031)
3.4 Global Transcatheter Mitral Valve Replacement (TMVR) Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Functional Mitral Regurgitation (FMR)
4.1.2 Degenerative Mitral Regurgitation (DMR)
4.2 Global Transcatheter Mitral Valve Replacement (TMVR) Sales Value by Application
4.2.1 Global Transcatheter Mitral Valve Replacement (TMVR) Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Transcatheter Mitral Valve Replacement (TMVR) Sales Value, by Application (2020-2031)
4.2.3 Global Transcatheter Mitral Valve Replacement (TMVR) Sales Value, by Application (%) (2020-2031)
4.3 Global Transcatheter Mitral Valve Replacement (TMVR) Sales Volume by Application
4.3.1 Global Transcatheter Mitral Valve Replacement (TMVR) Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Transcatheter Mitral Valve Replacement (TMVR) Sales Volume, by Application (2020-2031)
4.3.3 Global Transcatheter Mitral Valve Replacement (TMVR) Sales Volume, by Application (%) (2020-2031)
4.4 Global Transcatheter Mitral Valve Replacement (TMVR) Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Transcatheter Mitral Valve Replacement (TMVR) Sales Value by Region
5.1.1 Global Transcatheter Mitral Valve Replacement (TMVR) Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Transcatheter Mitral Valve Replacement (TMVR) Sales Value by Region (2020-2025)
5.1.3 Global Transcatheter Mitral Valve Replacement (TMVR) Sales Value by Region (2026-2031)
5.1.4 Global Transcatheter Mitral Valve Replacement (TMVR) Sales Value by Region (%), (2020-2031)
5.2 Global Transcatheter Mitral Valve Replacement (TMVR) Sales Volume by Region
5.2.1 Global Transcatheter Mitral Valve Replacement (TMVR) Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Transcatheter Mitral Valve Replacement (TMVR) Sales Volume by Region (2020-2025)
5.2.3 Global Transcatheter Mitral Valve Replacement (TMVR) Sales Volume by Region (2026-2031)
5.2.4 Global Transcatheter Mitral Valve Replacement (TMVR) Sales Volume by Region (%), (2020-2031)
5.3 Global Transcatheter Mitral Valve Replacement (TMVR) Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Transcatheter Mitral Valve Replacement (TMVR) Sales Value, 2020-2031
5.4.2 North America Transcatheter Mitral Valve Replacement (TMVR) Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Transcatheter Mitral Valve Replacement (TMVR) Sales Value, 2020-2031
5.5.2 Europe Transcatheter Mitral Valve Replacement (TMVR) Sales Value by Country (%), 2024 VS 2031
